Global Network Point-of-Care Glucose Testing Device Market is valued at approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xxx% over the forecast period 2023-2030. A network point-of-care glucose testing device is a medical device used to measure blood glucose levels in real-time at the point of care, such as a hospital, clinic, or doctor’s office. This device is connected to a network, which allows for data transfer and sharing, enabling remote monitoring and management of patients with diabetes. The Network Point-of-Care Glucose Testing Device market is expanding because of factors such as increasing cases of diabetes and growing demand for medical testing kits. Network point-of-care glucose testing devices can provide an efficient and effective means of managing diabetes by allowing for real-time glucose monitoring, data sharing, and remote management, leading to improved patient outcomes and quality of care. Its prevalence has progressively increased during the last few decades.

According to the World Health Organization, diabetes affected 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, as per the International Diabetes Federation, the total number is predicted to rise to 643 million by 2030 and to 783 million by 2045. An estimated 44.7% of adults living with diabetes are undiagnosed and over 81% of these people live in low- and middle-income countries. Diabetes was responsible for an estimated USD 966 billion in global health expenditure in 2021. Another major component driving space is growing demand for medical testing kits. According to Statista, the sales of medical devices generated revenue of USD 480.97 billion in 2021. Revenue from medical devices was forecast to grow even further in the following years, reaching USD 570.80 billion by 2024. In addition, in 2021, 42 percent of healthcare organizations in the European Union were employing AI technologies for disease identification, with an additional 19% intending to carry out within the next three years. Also, increasing demand to incorporate patient data and rising government initiatives for diagnosis of diabetes would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Network Point-of-Care Glucose Testing Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Network Point-of-Care Glucose Testing Device Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to of the region’s rising disease prevalence. Furthermore, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing geriatric and target demographics, as well as regional growth of main market participants.

Major market players included in this report are:

F. Hoffmann-La Roche AG
Danaher Corporation
Abbott Laboratories
Nipro India Corporation Pvt Ltd.
Nova Biomedical
ACON Laboratories, Inc.
Trividia Health, Inc.
Prodigy Diabetes Care, LLC
Bayer AG/Ascensia Diabetes Care Holdings AG
EKF Diagnostics

Recent Developments in the Market:
? In October 2022, Roche launched a quick antigen diagnostic kit for detecting the COVID-19 coronavirus, with three additional configurations to be tested at home as well as by healthcare professionals.

Global Network Point-of-Care Glucose Testing Device Market Report Scope:
? Historical Data – 2020 - 2021
? Base Year for Estimation – 2022
? Forecast period - 2023-2030
? Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
? Segments Covered -Application, Type, Region
? Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
? Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type
0.5uL
1uL
5uL
Others

By Application
Hospital
Clinic
Household

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa